A novel objective evaluation method, shear wave elastography, in the treatment of atrophic vaginitis by nonablative intravaginal Er:YAG laser, a randomized-sham controlled pilot study
article
OA: closed
CC0
Abstract
OBJECTIVE: The aim of the study was to investigate the effectiveness of intravaginal Er:YAG laser for treating atrophic vaginitis in postmenopausal women utilizing shear wave elastography. METHODS: In this prospective randomized sham-controlled double-blind pilot study, 20 participants were included (laser group [n = 12] / sham-control group [n = 8]). A nonablative (Smooth mode) Er:YAG laser with a wavelength of 2,940 nm was used. Objective evaluation of laser treatment efficacy was conducted using a special ultrasonic technique: shear wave elastography. Ultrasonic velocity measurements were taken from the anterior and posterior vaginal walls. Mean elasticity (E mean ) was expressed in kilopascals (kPa). Additional outcome parameters were vaginal pH, Vaginal Health Index (VHI), Female Sexual Function Index (FSFI), and visual analog scale (VAS) scores for dyspareunia. RESULTS: Baseline clinical characteristics, vaginal pH, VHI, VAS and FSFI scores, and E mean values were comparable between the laser and sham-control groups. Statistically significant differences were observed in the final E mean values of the anterior vaginal wall (13.1 ± 6.3 vs 20.0 ± 3.3 kPA, P = 0.01) and posterior vaginal wall (12.7 ± 10.3 vs 19.4 ± 6.9 kPA, P = 0.04) between the laser and sham-control group. Despite comparable baseline E mean values, significant differences in vaginal wall stiffness posttreatment indicated a notable increase in tissue elasticity following laser treatment. Statistically significant differences were also observed in final vaginal pH values, VHI, VAS scores, and FSFI score improvement in favor of laser treatment. CONCLUSIONS: Shear wave elastography may be considered as a reliable and objective technique for evaluating the efficacy of Er:YAG laser treatment in women with atrophic vaginitis. However, additional studies with larger sample sizes are necessary to establish conclusive evidence.
Full text
1,913 characters
· extracted from
oa-doi-fallback
· 4 sections
· click to expand
Objective
The aim of the study was to investigate the effectiveness of intravaginal Er:YAG laser for treating atrophic vaginitis in postmenopausal women utilizing shear wave elastography.
Methods
In this prospective randomized sham-controlled double-blind pilot study, 20 participants were included (laser group [n = 12] / sham-control group [n = 8]). A nonablative (Smooth mode) Er:YAG laser with a wavelength of 2,940 nm was used. Objective evaluation of laser treatment efficacy was conducted using a special ultrasonic technique: shear wave elastography. Ultrasonic velocity measurements were taken from the anterior and posterior vaginal walls. Mean elasticity (Emean) was expressed in kilopascals (kPa). Additional outcome parameters were vaginal pH, Vaginal Health Index (VHI), Female Sexual Function Index (FSFI), and visual analog scale (VAS) scores for dyspareunia.
Results
Baseline clinical characteristics, vaginal pH, VHI, VAS and FSFI scores, and Emean values were comparable between the laser and sham-control groups. Statistically significant differences were observed in the final Emean values of the anterior vaginal wall (13.1 ± 6.3 vs 20.0 ± 3.3 kPA, P = 0.01) and posterior vaginal wall (12.7 ± 10.3 vs 19.4 ± 6.9 kPA, P = 0.04) between the laser and sham-control group. Despite comparable baseline Emean values, significant differences in vaginal wall stiffness posttreatment indicated a notable increase in tissue elasticity following laser treatment. Statistically significant differences were also observed in final vaginal pH values, VHI, VAS scores, and FSFI score improvement in favor of laser treatment.
Conclusions
Shear wave elastography may be considered as a reliable and objective technique for evaluating the efficacy of Er:YAG laser treatment in women with atrophic vaginitis. However, additional studies with larger sample sizes are necessary to establish conclusive evidence.
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Outcome instruments
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (40)
- Elastosonography: a possible new tool for diagnosis of adenomyosis? via openalex
- Importance of Transvaginal Ultrasound Applying Elastography for Identifying Deep Infiltrating Endometriosis – A Feasibility Study via openalex
- doi:10.3109/13697137.2015.1078668 via openalex
- doi:10.1111/1471-0528.16558 via openalex
- doi:10.1371/journal.pone.0175747 via openalex
- doi:10.4103/gmit.gmit_141_20 via openalex
- doi:10.5978/islsm.14-or-11 via openalex
- doi:10.1210/jc.2010-0766 via openalex
- doi:10.1210/clinem/dgaa764 via openalex
- doi:10.1002/lsm.22637 via openalex
- doi:10.1016/j.ajog.2016.07.045 via openalex
- doi:10.1080/13697137.2018.1436538 via openalex
- doi:10.1038/nrendo.2017.180 via openalex
- doi:10.1002/lsm.22569 via openalex
- doi:10.3109/13697137.2015.1071608 via openalex
- doi:10.1097/gme.0000000000001353 via openalex
- doi:10.1097/gme.0000000000000761 via openalex
- doi:10.1016/j.ejogrb.2018.08.010 via openalex
- doi:10.1097/gme.0000000000001609 via openalex
- doi:10.1016/j.ajog.2005.07.096 via openalex
- doi:10.1016/j.maturitas.2023.02.001 via openalex
- doi:10.1002/lsm.23748 via openalex
- doi:10.1080/13697137.2020.1804544 via openalex
- doi:10.3109/13697137.2015.1045485 via openalex
- W4207044768 via openalex
- doi:10.1002/jum.15018 via openalex
- W4225608353 via openalex
- doi:10.1007/s10103-021-03484-x via openalex
- doi:10.1007/s00432-018-2614-8 via openalex
- doi:10.1186/s40001-023-01378-y via openalex
- doi:10.1097/gme.0b013e3182a122c2 via openalex
- doi:10.1093/aje/kws421 via openalex
- doi:10.1007/s10517-017-3650-0 via openalex
- doi:10.1007/s10103-021-03305-1 via openalex
- doi:10.1080/13697137.2020.1764525 via openalex
- doi:10.1097/gme.0b013e318295236f via openalex
- doi:10.3109/13697137.2015.1070564 via openalex
- doi:10.1097/gme.0b013e318282600b via openalex
- doi:10.1016/j.maturitas.2015.08.001 via openalex
- doi:10.1016/0378-5122(95)00956-6 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T04:17:14.223806+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0
· commercial use OK